Suppr超能文献

饮食植物类黄酮预防肥胖和糖尿病。

Dietary plant flavonoids in prevention of obesity and diabetes.

机构信息

Department of Chemistry, Tripura University, Agartala, Tripura, India.

Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, VA, United States.

出版信息

Adv Protein Chem Struct Biol. 2020;120:159-235. doi: 10.1016/bs.apcsb.2019.08.006. Epub 2019 Dec 12.

Abstract

Obesity and diabetes are the most prevailing chronic metabolic diseases worldwide from mainly lipid and glucose metabolic dysfunctions and their incidence is increasing at an alarming high rate. Obesity is characterized by excess fat accumulation in WAT and liver and is the central player of insulin resistance in the peripheral tissues from chronic inflammation, lipotoxicity and gut dysbiosis, and plays a key role for development of type 2 diabetes (T2DM) and vascular diseases. Diabetes mellitus, known as diabetes, is chiefly characterized by hyperglycaemia from impaired insulin secretion and insulin resistance. Several identified mutant genes in insulin secretion and resistance and various environmental factors are considered responsible for the onset of this disease. Currently available oral synthetic drugs, biguanides, incretin mimetic, GLP-1R and PPAR agonists and DPP-4 inhibitors for management of obesity and diabetes have several adverse effects in patients on long-term use. Emerging evidence supports the efficacy of dietary plant flavonoids in prevention and attenuation of obesity and diabetes by the protection and proliferation of pancreatic beta-cells and improvement of their insulin secretory function via activation of cAMP/PKA signaling pathway as well as in the improvement of insulin sensitivity in the peripheral metabolic tisssues for glucose uptake and utilization via inhibition of inflammation, lipotoxicity and oxidative stress. These flavonoids improve GLUT-4 expression and translocation to plasma membrane by activation of insulin-sensitive PI3K/Akt signaling and insulin-independent AMPK, SIRT-1 and MOR activation pathways for regulation of glucose homeostasis, and improve fat oxidation and reduce lipid synthesis by regulation of related genes for lipid homeostasis in the body of obese diabetic animals. In this chapter, we have highlighted all these beneficial anti-obesity and antidiabetic potentials of some dietary plant flavonoids along with their molecular actions, bioavailability and pharmacokinetics. In addition, the present understanding and management of obesity and diabetes are also focused.

摘要

肥胖和糖尿病是全球最普遍的慢性代谢性疾病,主要表现为脂质和葡萄糖代谢功能紊乱,其发病率呈惊人的高速增长。肥胖的特征是 WAT 和肝脏中脂肪过度积累,是外周组织胰岛素抵抗的核心,其原因是慢性炎症、脂毒性和肠道菌群失调,并且在 2 型糖尿病(T2DM)和血管疾病的发展中起着关键作用。糖尿病,又称糖尿病,主要特征是胰岛素分泌受损和胰岛素抵抗导致的高血糖。已鉴定出的胰岛素分泌和抵抗的突变基因以及各种环境因素被认为是导致这种疾病发生的原因。目前用于肥胖和糖尿病管理的口服合成药物、双胍类药物、肠促胰岛素类似物、GLP-1R 和 PPAR 激动剂以及 DPP-4 抑制剂在长期使用的患者中存在多种不良反应。新出现的证据支持膳食植物类黄酮在预防和减轻肥胖和糖尿病方面的功效,其通过保护和增殖胰岛β细胞,改善其胰岛素分泌功能,通过激活 cAMP/PKA 信号通路,以及通过抑制炎症、脂毒性和氧化应激来改善外周代谢组织的胰岛素敏感性。这些类黄酮通过激活胰岛素敏感的 PI3K/Akt 信号和胰岛素非依赖性 AMPK、SIRT-1 和 MOR 激活途径来改善 GLUT-4 的表达和向质膜的易位,以调节葡萄糖稳态,通过调节与肥胖糖尿病动物体内脂质稳态相关的基因来改善脂肪氧化和减少脂质合成。在本章中,我们强调了一些膳食植物类黄酮的这些有益的抗肥胖和抗糖尿病潜力及其分子作用、生物利用度和药代动力学。此外,还重点关注了目前对肥胖和糖尿病的理解和管理。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验